Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
Aurobindo Pharma (NSE:AUROPHARMA) Announces Q2FY27 Earnings Call Date and Details
Read More
|
|
Aurobindo Pharma Q2FY27 Earnings Call Set for 5 Nov 2026
Read More
|
|
What Aurobindo Pharma Shareholders Got Right
Read More
|
|
Aurobindo Pharma Ltd Estimates – NSE:AUROPHARMA
Read More
|
|
Sona BLW, Solar Industries, Oracle, Aurobindo Pharma, CG Power: Midcap performers of 2026, price targets and more
Read More
|
|
Aurobindo Pharma's Apitoria Acquires 80% Stake in A1 Biochem Labs India
Read More
|
|
Aurobindo arm Apitoria completes $15.25 million acquisition of A1 Biochem Labs
Read More
|
|
Aurobindo Pharma completes A1 Biochem CRO acquisition to build integrated CRDMO platform
Read More
|
|
Aurobindo subsidiary completes US CRDMO acquisition for $15.247 million
Read More
|
|
Aurobindo Arm Acrotech Launches ADQUEY in US for Atopic Dermatitis, Enters Dermatology Market
Read More
|
|
Aurobindo Pharma launches Adquey in US; Nuvama sees $300 million peak sales
Read More
|
|
Aurobindo Pharma Launches Adquey Ointment in US
Read More
|